Condition: Ankylosing Spondyloarthritis · Sponsor: University Hospital, Clermont-Ferrand
Subclinical intestinal inflammation and gut dysbiosis have been reported in patients with spondyloarthritis (SpA). In common practice, rheumatologists are increasingly confronted with patients with inflammatory rheumatism who are on gluten-free diets (GFDs), despite the lack of reliable data from controlled studies. This study aims to determine the impact of a GFD on the quality of life of patients with axial SpA.
This description comes directly from the study's public registry record.
Lise Laclautre, Pharm D · 334.73.754.963 · promo_interne_drci@chu-clermontferrand.fr
Always discuss trial participation with your own doctor first.
| CHU de Bordeaux | Bordeaux, France | Not Yet Recruiting |
| CHU de Clermont-Ferrand | Clermont-Ferrand, France | Recruiting |
| CHU de Grenoble | Grenoble, France | Not Yet Recruiting |
| Hospices Civils de Lyon | Lyon, France | Not Yet Recruiting |
| CHU de Montpellier | Montpellier, France | Not Yet Recruiting |
| Assistance Publique - Hôpitaux de Paris (AP-HP) - Hôpital Cochin | Paris, France | Not Yet Recruiting |
| CHU de Saint-Etienne | Saint-Etienne, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04274374